Literature DB >> 15075409

Structural stability and heat-induced conformational change of two complement inhibitors: C4b-binding protein and factor H.

Lena Kask1, Bruno O Villoutreix, Mårten Steen, Bala Ramesh, Björn Dahlbäck, Anna M Blom.   

Abstract

The complement inhibitors C4b-binding protein (C4BP) and factor H (FH) both consist of complement control protein (CCP) domains. Here we examined the secondary structure of both proteins by circular dichroism and Fourier-transform infrared technique at temperatures ranging from 30 degrees C-90 degrees C. We found that predominantly beta-sheet structure of both proteins was stable up to 70 degrees C, and that a reversible conformational change toward alpha-helix was apparent at temperatures ranging from 70 degrees C to 90 degrees C. The ability of both proteins to inhibit complement was not impaired after incubation at 95 degrees C, exposure to extreme pH conditions, and storage at room temperature for several months. Similar remarkable stability was previously observed for vaccinia virus control protein (VCP), which is also composed of CCP domains; it therefore seems to be a general property of CCP-containing proteins. A typical CCP domain has a hydrophobic core, which is wrapped in beta-sheets and stabilized by two disulphide bridges. How the CCP domains tolerate harsh conditions is unclear, but it could be due to a combination of high content of prolines, hydrophobic residues, and the presence of two disulphide bridges within each domain. These findings are of interest because CCP-containing complement inhibitors have been proposed as clinical agents to be used to control unwanted complement activation that contributes to many diseases.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15075409      PMCID: PMC2286748          DOI: 10.1110/ps.03516504

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  44 in total

1.  Each of the three binding sites on complement factor H interacts with a distinct site on C3b.

Authors:  T S Jokiranta; J Hellwage; V Koistinen; P F Zipfel; S Meri
Journal:  J Biol Chem       Date:  2000-09-08       Impact factor: 5.157

2.  A novel interaction of outer membrane protein A with C4b binding protein mediates serum resistance of Escherichia coli K1.

Authors:  Nemani V Prasadarao; Anna M Blom; Bruno O Villoutreix; Linette C Linsangan
Journal:  J Immunol       Date:  2002-12-01       Impact factor: 5.422

3.  Human polymorphonuclear leukocytes adhere to complement factor H through an interaction that involves alphaMbeta2 (CD11b/CD18).

Authors:  R G DiScipio; P J Daffern; I U Schraufstätter; P Sriramarao
Journal:  J Immunol       Date:  1998-04-15       Impact factor: 5.422

4.  Antiphagocytic activity of streptococcal M protein: selective binding of complement control protein factor H.

Authors:  R D Horstmann; H J Sievertsen; J Knobloch; V A Fischetti
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

5.  Inhibition of complement components C3 and C4 by cadralazine and its active metabolite.

Authors:  M Andersson; A Hanson; G Englund; B Dahlbäck
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

6.  Complement factor H is a serum-binding protein for adrenomedullin, and the resulting complex modulates the bioactivities of both partners.

Authors:  R Pio; A Martinez; E J Unsworth; J A Kowalak; J A Bengoechea; P F Zipfel; T H Elsasser; F Cuttitta
Journal:  J Biol Chem       Date:  2000-12-14       Impact factor: 5.157

7.  Identification of the second heparin-binding domain in human complement factor H.

Authors:  T K Blackmore; J Hellwage; T A Sadlon; N Higgs; P F Zipfel; H M Ward; D L Gordon
Journal:  J Immunol       Date:  1998-04-01       Impact factor: 5.422

8.  Thrombin-mediated proteolysis of factor V resulting in gradual B-domain release and exposure of the factor Xa-binding site.

Authors:  Mårten Steen; Björn Dahlbäck
Journal:  J Biol Chem       Date:  2002-08-05       Impact factor: 5.157

9.  Characterization of the interaction of human C4b-binding protein with physiological ligands.

Authors:  R J Ziccardi; B Dahlback; H J Müller-Eberhard
Journal:  J Biol Chem       Date:  1984-11-25       Impact factor: 5.157

10.  Novel subunit in C4b-binding protein required for protein S binding.

Authors:  A Hillarp; B Dahlbäck
Journal:  J Biol Chem       Date:  1988-09-05       Impact factor: 5.157

View more
  12 in total

1.  Complement regulator C4BP binds to Staphylococcus aureus surface proteins SdrE and Bbp inhibiting bacterial opsonization and killing.

Authors:  Pamela S Hair; Caitlin K Foley; Neel K Krishna; Julius O Nyalwidhe; Joan A Geoghegan; Timothy J Foster; Kenji M Cunnion
Journal:  Results Immunol       Date:  2013-11-09

2.  Complement-mediated bactericidal activity of anti-factor H binding protein monoclonal antibodies against the meningococcus relies upon blocking factor H binding.

Authors:  Serena Giuntini; Donald C Reason; Dan M Granoff
Journal:  Infect Immun       Date:  2011-06-27       Impact factor: 3.441

3.  Binding of Complement Factor H (FH) Decreases Protective Anti-FH Binding Protein Antibody Responses of Infant Rhesus Macaques Immunized With a Meningococcal Serogroup B Vaccine.

Authors:  Dan M Granoff; Isabella Costa; Monica Konar; Serena Giuntini; Koen K A Van Rompay; Peter T Beernink
Journal:  J Infect Dis       Date:  2015-02-12       Impact factor: 5.226

4.  The Hidden Side of Complement Regulator C4BP: Dissection and Evaluation of Its Immunomodulatory Activity.

Authors:  Inmaculada Serrano; Ana Luque; Francesca Mitjavila; Anna M Blom; Santiago Rodríguez de Córdoba; M Cristina Vega; Joan Torras; Josep M Aran
Journal:  Front Immunol       Date:  2022-04-25       Impact factor: 8.786

5.  Painting factor H onto mesenchymal stem cells protects the cells from complement- and neutrophil-mediated damage.

Authors:  Yan Li; Wen Qiu; Lingjun Zhang; John Fung; Feng Lin
Journal:  Biomaterials       Date:  2016-06-08       Impact factor: 12.479

6.  Functional mapping of YadA- and Ail-mediated binding of human factor H to Yersinia enterocolitica serotype O:3.

Authors:  Marta Biedzka-Sarek; Saara Salmenlinna; Markus Gruber; Andrei N Lupas; Seppo Meri; Mikael Skurnik
Journal:  Infect Immun       Date:  2008-09-02       Impact factor: 3.441

7.  C4BP-IgM protein as a therapeutic approach to treat Neisseria gonorrhoeae infections.

Authors:  Serena Bettoni; Jutamas Shaughnessy; Karolina Maziarz; David Ermert; Sunita Gulati; Bo Zheng; Matthias Mörgelin; Susanne Jacobsson; Kristian Riesbeck; Magnus Unemo; Sanjay Ram; Anna M Blom
Journal:  JCI Insight       Date:  2019-12-05

8.  Regulatory components of the alternative complement pathway in endothelial cell cytoplasm, factor H and factor I, are not packaged in Weibel-Palade bodies.

Authors:  Nancy A Turner; Sarah E Sartain; Shiu-Ki Hui; Joel L Moake
Journal:  PLoS One       Date:  2015-03-24       Impact factor: 3.240

9.  Functional Analysis of the Human Antibody Response to Meningococcal Factor H Binding Protein.

Authors:  Peter T Beernink; Serena Giuntini; Isabella Costa; Alexander H Lucas; Dan M Granoff
Journal:  MBio       Date:  2015-06-23       Impact factor: 7.867

10.  High-throughput thermal stability analysis of a monoclonal antibody by attenuated total reflection FT-IR spectroscopic imaging.

Authors:  Maxime Boulet-Audet; Bernadette Byrne; Sergei G Kazarian
Journal:  Anal Chem       Date:  2014-09-26       Impact factor: 6.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.